Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
NeuroOne Medical Technologies Corporation (NMTC) had Return on Tangible Equity of -192.53% for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
$3.41M |
|
$-11.86M |
|
$1.50M |
|
$1.91M |
|
$15.36M |
|
$-11.96M |
|
$0.10M |
|
$-11.86M |
|
$-11.86M |
|
$-11.86M |
|
$-11.86M |
|
$-11.86M |
|
$-11.86M |
|
$-11.96M |
|
$-11.80M |
|
18.12M |
|
18.12M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$7.31M |
|
$0.53M |
|
$0.78M |
|
$8.10M |
|
$1.79M |
|
-- |
|
$0.06M |
|
$1.85M |
|
$6.25M |
|
$6.16M |
|
$6.25M |
|
23.93M |
|
| Cash Flow Statement Financials | |
$-12.89M |
|
$2.65M |
|
$7.40M |
|
$8.16M |
|
$5.32M |
|
$-2.84M |
|
$1.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
56.10% |
|
-350.84% |
|
-350.84% |
|
-346.33% |
|
-348.03% |
|
-348.03% |
|
$-13.26M |
|
-- |
|
-- |
|
-- |
|
0.42 |
|
0.87 |
|
-- |
|
-- |
|
-189.77% |
|
|
Return on Tangible Equity |
-192.53% |
-146.46% |
|
-189.77% |
|
$0.26 |
|
$-0.73 |
|
$-0.71 |
|